sepsi
lifethreaten
organ
dysfunct
caus
dysregul
host
respons
infect
sepsi
caus
broad
rang
pathogen
howev
bacteri
infect
repres
major
sepsi
case
sepsi
present
cultur
neg
suggest
nonbacteri
caus
despit
diagnosi
viral
sepsi
remain
rare
almost
viru
caus
sepsi
vulner
patient
eg
neonat
infant
immunosuppress
group
preval
viral
sepsi
known
enough
inform
make
accur
estim
initi
standard
care
case
sepsi
even
subsequ
proven
cultur
neg
immedi
use
broadspectrum
antibiot
absenc
definit
diagnost
criteria
viral
sepsi
least
exclud
bacteri
sepsi
inevit
lead
unnecessari
antimicrobi
use
associ
consequ
antimicrobi
resist
effect
host
microbiom
excess
healthcar
cost
import
understand
nonbacteri
caus
sepsi
inappropri
treatment
minimis
appropri
treatment
develop
improv
outcom
review
summaris
known
viral
sepsi
common
caus
immun
respons
sever
viral
infect
contribut
sepsi
also
discuss
strategi
improv
understand
viral
sepsi
way
integr
new
inform
effect
treatment
main
differ
previou
version
elimin
term
sepsi
syndrom
sever
sepsi
introduc
new
definit
sepsi
compar
older
definit
sever
sepsi
addit
system
inflammatori
respons
syndrom
sir
criteria
essenti
element
longer
use
defin
sepsi
still
play
role
recognit
infect
warrant
earli
intervent
possibl
sepsi
provid
specif
univers
definit
sepsi
would
improv
clinic
manag
facilit
epidemiolog
survey
also
better
predict
abil
inhospit
mortal
howev
design
paediatr
popul
carri
high
burden
sepsi
current
widelyus
consensu
definit
paediatr
sepsi
propos
still
built
sir
criteria
shown
lack
specif
perform
poorli
identifi
children
high
risk
mortal
infect
addit
feasibl
applic
appli
nonintens
care
set
lowand
middleincom
countri
remain
question
evid
suggest
may
use
appli
definit
paediatr
popul
howev
mani
children
sever
viral
respiratori
tract
infect
eg
bronchiol
fulfil
criteria
viral
sepsi
gener
clinician
would
regard
septic
highlight
difficulti
provid
robust
definit
viral
sepsi
therefor
urgent
need
conven
consensu
task
forc
design
paediatr
definit
although
bacteri
fungal
infect
commonli
attribut
caus
sepsi
sepsi
infrequ
attribut
viral
infect
case
viral
sepsi
regard
virusinduc
direct
tissu
cell
damag
eg
influenza
virusinduc
pulmonari
epitheli
damag
instead
system
dysregul
caus
viru
howev
abovement
consensu
definit
sepsi
either
adult
paediatr
popul
pathogenspecif
definit
also
appli
viral
infect
therefor
review
articl
viral
sepsi
defin
lifethreaten
organ
dysfunct
due
dysregul
host
respons
viral
infect
adult
paediatr
popul
viral
infect
diagnos
associ
clinic
present
plu
posit
result
cultur
antigen
detect
molecular
detect
eg
polymeras
chain
reaction
pcr
serolog
histopatholog
immunohistochemistri
viral
sepsi
alway
consid
septic
patient
lack
evid
bacteri
parasit
fungal
infect
laboratori
test
virus
arrang
accordingli
follow
section
review
current
evid
avail
epidemiolog
aetiolog
immun
pathogenesi
potenti
treatment
viral
sepsi
avail
largescal
epidemiolog
studi
sepsi
base
criteria
sever
sepsi
defin
similar
definit
sepsi
accord
criteria
therefor
avail
use
data
sever
sepsi
studi
base
repres
epidemiolog
data
sepsi
defin
gener
incid
sever
sepsi
climb
time
wherea
sepsisassoci
mortal
declin
recent
systemat
review
metaanalysi
report
global
incid
mortal
hospitaltr
sepsi
adult
popul
per
personyear
respect
last
decad
extrapol
figur
translat
global
estim
million
sepsi
case
million
death
annual
anoth
global
studi
found
incid
mortal
sepsi
paediatr
popul
week
year
age
per
personyear
respect
incid
mortal
neonat
sepsi
definit
per
live
birth
respect
extrapol
data
result
global
estim
million
sepsi
episod
neonat
million
episod
paediatr
popul
annual
infectionrel
mortal
outsid
neonat
period
fall
sepsi
episod
rate
emphasis
import
focu
tackl
sepsi
first
week
life
studi
indic
sever
limit
epidemiolog
survey
sepsi
firstli
populationlevel
data
avail
lowincom
countri
repres
world
popul
bear
huge
burden
infecti
diseas
sepsi
therefor
figur
like
underestim
secondli
lack
univers
specif
sepsi
definit
sever
criteria
lead
substanti
heterogen
case
definit
among
studi
lastli
studi
may
use
differ
denomin
calcul
incid
mortal
eg
personyear
specifi
popul
live
birth
hurdl
make
metaanalysi
challeng
suscept
bia
top
limit
epidemiolog
studi
sepsi
either
exclud
case
viral
origin
specifi
proport
viral
sepsi
organ
contribut
sepsi
identifi
septic
patient
ie
document
sepsi
bacteria
usual
account
document
sepsi
case
virus
contribut
document
sepsi
case
studi
howev
figur
like
underst
preval
viral
sepsi
sever
reason
recent
southeast
asian
prospect
studi
use
predefin
set
laboratori
test
includ
pcr
test
multipl
virus
demonstr
virus
account
document
sepsi
case
definit
paediatr
exclud
neonat
adult
popul
respect
common
virus
identifi
dengu
virus
follow
rhinoviru
influenza
virus
respiratori
syncyti
viru
although
studi
conduct
tropic
middleincom
countri
use
definit
still
provid
direct
evid
viral
sepsi
may
underdiagnos
diagnost
test
virus
perform
howev
identifi
virus
could
singl
caus
agent
sepsi
eg
dengu
contributor
secondari
bacteri
sepsi
eg
influenza
staphylococc
sepsi
coinfect
unknown
signific
eg
rhinoviru
prolong
persist
shed
previou
infect
eg
adenoviru
innoc
latent
infect
eg
epsteinbarr
viru
fals
posit
result
also
need
taken
clinic
context
exampl
profoundli
immunosuppress
child
respiratori
symptom
high
rhinoviru
viral
load
blood
would
suggest
rhinoviru
caus
sepsi
howev
previous
well
child
purul
mening
rhinoviru
nasal
swab
would
uncertainti
anoth
major
obstacl
studi
epidemiolog
viral
sepsi
particularli
case
bacteri
infect
also
document
identifi
viru
usual
caus
fulmin
diseas
role
identifi
viru
play
septic
patient
still
area
debat
similarli
anoth
prospect
studi
demonstr
third
adult
patient
requir
intens
care
sever
pneumonia
viral
infect
detect
predefin
array
diagnost
test
includ
pcr
test
multipl
virus
pneumonia
common
clinic
syndrom
patient
sepsi
moreov
anoth
prospect
studi
found
patient
cultureneg
sepsi
significantli
lower
level
procalcitonin
document
sepsi
shown
elev
procalcitonin
level
like
seen
bacteri
infect
viral
infect
may
use
differenti
infect
caus
bacteria
virus
therefor
studi
suggest
virus
may
caus
sepsi
case
exact
incid
viral
sepsi
remain
elucid
world
health
organ
world
health
assembl
list
sepsi
one
global
health
prioriti
follow
year
also
recogn
import
understand
epidemiolog
burden
sepsi
order
obtain
comprehens
pictur
burden
sepsi
urgent
need
understand
epidemiolog
viral
sepsi
almost
viru
caus
viral
sepsi
suscept
popul
herp
simplex
viru
hsv
enterovirus
common
viral
caus
neonat
sepsi
enterovirus
human
parechovirus
hpev
common
caus
viral
sepsi
young
children
addit
influenza
virus
major
caus
sever
infect
death
among
children
younger
year
age
older
adult
pregnant
women
immunosuppress
individu
also
lead
substanti
morbid
mortal
older
children
adult
age
group
furthermor
dengu
virus
lead
caus
sepsi
tropic
countri
review
characterist
epidemiolog
promin
caus
viral
sepsi
follow
section
hsv
one
lead
caus
neonat
sepsi
neonat
hsv
caus
three
type
diseas
skin
eye
mouth
diseas
enceph
dissemin
diseas
dissemin
hsv
diseas
sever
form
hsv
infect
case
fatal
rate
high
patient
lethargi
sever
hepat
dysfunct
delay
treatment
higher
mortal
hsv
also
caus
fulmin
hepat
nonneonat
popul
typic
without
obviou
cholestasi
dissemin
hsv
diseas
fulmin
hsv
hepat
clinic
present
viral
sepsi
involv
hepat
dysfunct
respiratori
failur
dissemin
intravascular
coagulopathi
haemodynam
instabl
absenc
skin
lesion
dissemin
hsv
diseas
hsv
hepat
difficult
differenti
clinic
sepsi
caus
pathogen
studi
report
variou
incid
rate
neonat
hsv
infect
rang
per
live
birth
dissemin
hsv
diseas
account
case
viral
factor
associ
viral
sepsi
firstli
larg
inoculum
hsv
may
increas
risk
viral
sepsi
secondli
shown
matern
genit
hsv
type
infect
higher
probabl
transmiss
neonat
labour
hsv
type
infect
howev
account
higher
proport
neonat
central
nervou
system
cn
dissemin
hsv
diseas
although
caus
case
neonat
hsv
infect
also
explain
associ
higher
morbid
mortal
furthermor
neonat
born
mother
newlyacquir
genit
hsv
infect
near
term
greater
risk
neonat
hsv
infect
born
mother
reactiv
genit
hsv
infect
enteroviru
genu
virus
famili
picornavirida
shown
caus
sepsi
immunodefici
paediatr
popul
enterovirus
caus
agent
broad
rang
clinic
condit
includ
asept
mening
myocard
although
mani
case
asymptomat
benign
million
symptomat
enterovir
infect
unit
state
per
year
disproportion
high
number
infect
occur
neonat
compar
averag
yearli
birth
cohort
percentag
enterovirus
highest
associ
sepsi
coxsackieviru
echoviru
virus
primarili
caus
sepsi
neonat
contrast
enteroviru
lead
viral
sepsi
children
beyond
neonat
period
predominantli
children
younger
year
age
risk
factor
neonat
enterovir
infect
includ
exposur
matern
secret
blood
deliveri
matern
infect
deliveri
lack
previou
matern
infect
infect
serotyp
result
low
matern
antibodi
level
serotyp
viru
major
sever
neonat
enterovir
infect
occur
day
life
suggest
acquisit
gener
perinat
period
preced
matern
infect
hpev
also
frequent
associ
sepsi
paediatr
immunodefici
popul
hpev
previous
defin
subset
genu
enteroviru
eventu
reclassifi
genu
virus
sequenc
reveal
unrel
enteroviru
antibodi
hpev
present
cerebrospin
fluid
csf
popul
hpev
type
common
caus
hpev
sepsi
present
popul
studi
netherland
finland
hpev
second
common
caus
viral
sepsi
young
children
enterovir
infect
hpev
infect
often
asymptomat
present
mild
symptom
although
sever
infect
symptom
rang
sepsi
sepsislik
ill
viral
mening
enceph
white
matter
abnorm
magnet
reson
imag
found
case
hpev
enceph
may
play
role
develop
sequela
develop
white
matter
abnorm
sequela
seem
show
littl
associ
short
term
outcom
clinic
present
hpev
infect
similar
enterovir
infect
clinic
indistinguish
requir
serolog
pcr
discrimin
hpev
commonli
associ
sever
diseas
hpev
known
caus
sever
diseas
rare
licens
specif
antivir
therapi
avail
hpev
enteroviru
infect
despit
rel
high
incid
neonat
enceph
system
infect
present
promis
target
futur
research
tangibl
way
reduc
incid
neonat
viral
sepsi
associ
infant
mortal
global
addit
pcr
test
hpev
reanalysi
bank
csf
sampl
children
present
sepsi
found
increas
detect
viral
caus
sepsi
case
hpev
found
neonat
present
sepsi
depend
year
overal
detect
rate
thu
like
viral
sepsi
caus
hpev
frequent
underdiagnos
influenza
b
virus
caus
season
epidem
outofseason
outbreak
worldwid
influenza
sepsi
present
sever
pneumonia
acut
respiratori
distress
syndrom
ard
myocard
encephalopathi
estim
annual
incid
proport
influenza
viru
infect
adult
children
model
studi
demonstr
season
influenza
epidem
account
estim
respiratori
death
annual
occur
among
children
younger
year
age
true
mortal
attribut
influenza
virus
must
higher
figur
includ
death
caus
circulatori
death
also
make
larg
proport
influenza
virusassoci
death
approxim
mortal
season
influenza
occur
peopl
older
year
age
nonsurvivor
influenza
pandem
peopl
younger
year
age
age
shift
may
explain
level
immun
strain
peopl
born
strain
wide
circul
replac
pandem
strain
addit
studi
found
high
titr
lowavid
nonprotect
immunoglobulin
g
viral
antigen
sever
ill
middleag
adult
patient
pulmonari
immun
complex
deposit
complement
activ
also
observ
provid
evid
immun
complexmedi
diseas
may
part
pathogenesi
sever
pneumonia
middleag
patient
also
contribut
age
shift
pathogenesi
influenza
viru
infect
depend
viral
virul
host
respons
host
respons
discuss
next
section
crucial
site
influenza
viru
infect
lead
sever
pneumonia
alveolar
epithelium
haemagglutinin
differ
strain
influenza
virus
vari
tropism
airway
epithelium
exampl
season
influenza
virus
bind
preferenti
epithelium
upper
airway
bronchi
lesser
extent
alveolar
epithelium
contrast
ha
pandem
influenza
viru
attach
type
type
pneumocyt
ha
avian
influenza
viru
primarili
bind
type
pneumocyt
second
determin
viral
virul
viral
polymeras
complex
associ
differ
level
viral
replic
cytokin
product
infect
epitheli
cell
therefor
differ
tropism
along
vari
degre
viral
replic
cytokin
product
induc
variou
extent
cell
death
part
explain
differ
pathogen
differ
strain
dengu
common
viral
infect
tropic
countri
capac
caus
viral
sepsi
dengu
virus
current
consid
import
widespread
viru
spread
mosquito
world
popul
live
area
dengu
infect
occur
estim
yearli
dengu
infect
rang
million
million
dengu
virus
member
famili
flavivirida
four
distinct
serotyp
serotyp
infect
serotyp
give
full
protect
serotyp
howev
infect
one
serotyp
infect
other
result
enhanc
sever
form
diseas
serotyp
dengu
virus
implic
sever
dengu
one
studi
thailand
found
patient
diagnos
sepsi
definit
test
posit
dengu
virus
upon
reanalysi
bank
serum
sampl
pcr
patient
diagnos
dengu
pcr
bank
serum
sampl
five
die
four
diagnos
sepsi
dengu
infect
suggest
may
prove
benefici
increas
test
dengu
virus
patient
present
sepsi
ensur
patient
receiv
appropri
treatment
tabl
summaris
clinic
syndrom
epidemiolog
risk
factor
sepsi
caus
virus
adenoviru
commonli
detect
virus
caus
sepsi
far
one
virus
chikungunya
viru
hantaviru
coronavirus
ebola
viru
lassa
viru
among
mani
other
also
major
contributor
viral
sepsi
across
globe
due
limit
data
mani
virus
immun
respons
pathogenesi
poorli
understood
addit
virus
occur
high
enough
incid
popul
highincom
countri
gain
signific
research
fund
may
chang
futur
effect
treatment
discov
frequent
occur
infect
less
common
diseas
becom
attract
research
neonat
young
children
pregnant
women
older
adult
immunosuppress
individu
especi
suscept
sever
infect
sepsi
review
current
evid
regard
immunolog
characterist
suscept
popul
predispos
sever
infect
especi
viral
sepsi
immatur
immun
system
neonat
predispos
infect
intracellular
pathogen
sepsi
one
remark
featur
neonat
innat
immun
system
bia
favour
type
helper
h
cell
respons
result
reduc
secret
proinflammatori
cytokin
interleukin
il
tumour
necrosi
factor
tnf
interferon
ifn
togeth
immatur
innat
immun
allow
pathogen
replic
spread
easili
contrast
neonat
monocyt
antigenpres
cell
display
preserv
even
enhanc
tolllik
receptor
tlr
mediat
product
cytokin
eg
addit
studi
shown
neonat
experi
highli
exagger
inflammatori
respons
pathway
pathway
respons
specif
antigen
exagger
respons
may
play
role
develop
sepsi
respons
viral
infect
also
featur
neonat
immun
system
increas
suscept
sever
viral
infect
firstli
neonat
monocyt
decreas
express
major
histocompat
complex
mhc
class
ii
lead
impair
antigen
present
secondli
neonat
dendrit
cell
reduc
product
tnf
type
ifn
impair
upregul
costimulatori
molecul
reduc
stimul
cell
prolifer
contribut
decreas
abil
clear
virus
addit
neonat
low
level
complement
compon
complement
respons
antibodyindepend
opson
lysi
pathogen
play
role
activ
enhanc
adapt
immun
infect
furthermor
quantit
qualit
defect
neonat
neutrophil
exampl
lower
level
neutrophil
stress
situat
sepsi
seen
neonat
qualit
defici
neonat
neutrophil
includ
impair
adhes
migrat
chemotaxi
amplif
defect
lead
reduc
abil
clear
virus
pathogen
lastli
immatur
adapt
immun
neonat
togeth
lack
preexist
immunolog
memori
increas
suscept
variou
pathogen
sever
infect
worth
note
suscept
sepsi
persist
beyond
neonat
period
ie
week
age
young
children
also
bear
substanti
burden
sepsi
peak
incid
per
popul
infant
group
definit
likewis
hospitalis
rate
viral
infect
influenza
respiratori
syncyti
viru
infect
highest
children
younger
year
age
addit
children
underli
diseas
eg
bronchopulmonari
dysplasia
congenit
heart
diseas
neurolog
disord
greater
risk
develop
sever
viral
infect
sepsi
pregnant
women
anoth
popul
greater
risk
viral
sepsi
gener
popul
sever
report
matern
sepsi
caus
influenza
herp
simplex
varicellazost
chikungunya
virus
among
other
recognit
problem
influenza
relat
mortal
late
pregnanc
led
number
countri
introduc
routin
influenza
vaccin
pregnanc
accord
global
burden
diseas
studi
estim
death
matern
sepsi
infect
global
account
total
death
matern
disord
incid
matern
sepsi
around
per
pregnanc
mortal
rate
unit
kingdom
unit
state
increas
trend
incid
mortal
matern
sepsi
seen
recent
decad
howev
studi
report
proport
women
viral
sepsi
matern
immun
system
complic
delic
modul
toler
patern
antigen
allogen
foetu
effici
identifi
defend
invad
pathogen
protect
mother
foetu
immunolog
characterist
pregnanc
depend
stage
gestat
area
focu
exampl
proinflammatori
type
helper
h
bias
statu
high
level
seen
pregnant
women
first
trimest
pregnanc
critic
embryo
implant
placent
initi
foetal
growth
follow
pregnant
women
develop
antiinflammatori
h
statu
increas
level
prostaglandin
e
foetu
grow
rapidli
labour
immun
system
shift
back
proinflammatori
h
statu
help
parturit
addit
epitheli
cell
reproduct
tract
downregul
low
level
cervic
fluid
pregnant
women
also
encount
reduc
level
immunoglobulin
g
decreas
number
helper
lymphocyt
throughout
pregnanc
matern
immun
system
yet
understood
complet
howev
know
constantli
chang
univers
suppress
uniqu
immun
profil
result
differ
respons
pathogen
may
make
pregnant
women
suscept
pathogen
depend
stage
pregnanc
addit
immun
respons
origin
placenta
also
influenc
matern
immun
respons
microorgan
exampl
insult
subclin
viral
infect
placenta
affect
matern
immun
system
increas
matern
suscept
variou
pathogen
includ
virus
older
adult
year
old
popul
significantli
greater
risk
sepsi
caus
gener
popul
older
adult
found
incid
sepsi
case
per
consider
higher
case
per
observ
gener
popul
mani
reason
increas
suscept
includ
higher
likelihood
comorbid
prolong
hospitalis
time
gener
weaker
immun
respons
immunosenesc
viral
sepsi
older
adult
present
one
seriou
upcom
global
health
problem
global
popul
older
adult
set
overtak
young
popul
therefor
import
understand
uniqu
condit
within
older
adult
better
facilit
develop
suitabl
treatment
mani
factor
involv
increas
suscept
older
adult
popul
sepsi
also
increas
suscept
viral
infect
thu
viral
sepsi
comorbid
sepsi
sever
viral
infect
diabet
mellitu
renal
failur
chronic
obstruct
pulmonari
diseas
heart
condit
obes
much
preval
older
adult
popul
mani
comorbid
older
adult
increas
risk
viral
sepsi
often
associ
immunosuppress
eg
renal
failur
immunosenesc
gradual
deterior
immun
system
brought
advanc
age
increas
suscept
viral
infect
develop
viral
sepsi
characteris
decreas
function
phagocyt
antigen
present
lymphocyt
well
decreas
cellular
replic
abil
respond
cytokin
stimulu
older
adult
also
experi
persist
cell
exhaust
part
due
constant
lowlevel
inflamm
thought
caus
accumul
selfdebri
brought
decreas
abil
clear
process
often
call
inflammag
characteris
elev
baselin
level
cytokin
anoth
factor
contribut
cell
exhaust
older
adult
prolong
length
inflammatori
state
infect
result
decreas
cell
replic
inhibit
costimul
antigen
present
cell
result
decreas
abil
effect
respond
infect
allow
viral
infect
easili
evad
erad
immun
system
develop
seriou
system
infect
number
immunosuppress
host
grown
consider
last
decad
due
widespread
use
cytoabl
chemotherapi
monoclon
antibodi
immunomodulatori
agent
neoplast
autoimmun
diseas
epidem
human
immunodefici
viru
hiv
increas
number
haematopoiet
stem
cell
transplant
hsct
solid
organ
transplant
sot
clinic
pictur
sepsi
immunosuppress
host
usual
diminish
nonspecif
make
difficult
diagnos
distinguish
noninfecti
caus
transplant
reject
thu
infect
sepsi
continu
major
caus
morbid
mortal
immunosuppress
host
multicentr
prospect
studi
unit
state
show
hsct
recipi
viral
infect
point
posttranspl
median
followup
day
infect
account
death
howev
author
specifi
mortal
rate
caus
viral
infect
individu
neutropenia
take
corticosteroid
mainli
impair
innat
immun
transplant
recipi
primarili
defect
adapt
immun
similar
immunocompet
host
mani
virus
abl
caus
sepsi
immunosuppress
host
particular
concern
exampl
hsct
sot
recipi
high
risk
infect
cytomegaloviru
cmv
herpesvirus
respiratori
virus
eg
adenoviru
influenza
viru
parainfluenza
viru
respiratori
syncyti
viru
transplant
recipi
time
viral
infect
vari
accord
type
transplant
antimicrobi
prophylaxi
receiv
host
donor
factor
like
occur
month
transplant
defect
cellmedi
immun
domin
graftversushost
diseas
occur
contrast
risk
infect
cmv
herpesvirus
respiratori
virus
may
lower
neutropen
host
patient
hiv
infect
individu
take
corticosteroid
transplant
recipi
primari
immunodefici
anoth
special
categori
diseas
compris
least
genet
disord
variabl
sever
affect
six
million
peopl
worldwid
popul
substanti
risk
dissemin
viral
infect
sepsi
young
children
inborn
error
signal
pathway
upstream
product
type
ifn
higher
risk
develop
lifethreaten
viral
infect
exampl
signal
transduc
activ
transcript
nuclear
factor
nf
essenti
modul
nemo
defici
lead
lethal
hsv
diseas
variou
sever
viral
infect
defici
interferon
regulatori
factor
also
lead
sever
viral
infect
due
decreas
downstream
ifn
signal
disord
demonstr
effect
viral
infect
snp
affect
cell
number
variat
receptor
compon
receptor
decreas
downstream
signal
ifn
addit
patient
sever
combin
immunodefici
major
defect
b
lymphocyt
develop
face
substanti
risk
infect
caus
wide
varieti
pathogen
eg
fulmin
adenoviru
hsv
infect
pattern
recognit
receptor
prr
respons
initi
detect
virus
recogn
pathogenassoci
molecular
pattern
pamp
eg
viral
rna
dna
damageassoci
molecular
pattern
damp
eg
host
dna
protein
sever
famili
prr
tlr
cytosol
rna
sensor
eg
retino
acidinduc
gene
rig
melanoma
differentiationassoci
gene
cytosol
dna
sensor
eg
absent
melanoma
protein
cyclic
gmpamp
synthas
encount
pathogen
prr
play
critic
role
activ
innat
immun
respons
recruit
leucocyt
first
innat
respons
stimul
product
proinflammatori
cytokin
immedi
antivir
effect
prevent
viru
spread
replic
mainli
exert
type
ifn
furthermor
prr
trigger
develop
virusspecif
adapt
immun
eg
cytotox
lymphocyt
antibodi
clear
virus
virusinfect
cell
lastli
prr
induc
secret
antiinflammatori
cytokin
help
resolv
proinflammatori
state
promot
tissu
repair
normal
immun
respons
viral
infect
summaris
figur
although
proinflammatori
cytokin
essenti
mediat
innat
immun
particularli
caus
host
damag
releas
damp
damag
tissu
cell
stimul
prr
signal
lead
chain
reaction
culmin
viral
sepsi
infect
clear
compris
major
prr
signal
pathway
activ
respons
hsv
infect
mani
clinic
featur
viral
sepsi
caus
hsv
attribut
exuber
respons
induc
tlr
signal
demonstr
level
neg
associ
surviv
hsv
enceph
neonat
cordblood
cell
mount
higher
level
proinflammatori
cytokin
challeng
hsv
adult
blood
cell
therefor
hsv
caus
higher
ratio
tnf
neonat
contribut
sever
inflamm
develop
sepsi
dysregul
secret
proinflammatori
cytokin
respons
hsv
infect
also
induc
product
high
mobil
group
box
protein
injur
cell
nuclear
protein
regul
dna
transcript
mount
proinflammatori
cytokin
respons
patholog
level
lead
releas
cytochrom
c
demonstr
peak
come
peak
cytochrom
c
clinic
case
neonat
dissemin
hsv
diseas
cytochrom
c
subsequ
activ
result
extens
apoptosi
apoptosi
respons
develop
multiorgan
dysfunct
septic
patient
human
enteroviru
infect
characteris
type
ifn
respons
induc
prr
respond
rna
virus
enteroviru
detect
found
primarili
involv
tlr
rigilik
receptor
rlr
signal
pathway
particular
tlr
implic
innat
respons
enterovirus
rlr
commonli
associ
enteroviru
infect
involv
detect
intracellular
rna
virus
found
play
small
role
develop
innat
immun
respons
enteroviru
infect
although
prr
signal
cascad
like
role
sens
enterovirus
role
yet
characteris
human
enterovirus
employ
divers
rang
strategi
evad
immun
respons
replic
strategi
critic
abil
caus
viral
sepsi
allow
viru
replic
suffici
caus
signific
inflamm
broad
strategi
immun
evas
use
enterovirus
interfer
innat
immun
signal
either
interf
avoid
initi
prr
recognit
polioviru
subvert
signal
induc
apoptosi
innat
immun
effector
cell
interf
downstream
cytokin
signal
pathway
evid
enteroviru
interfer
ifn
signal
pathway
sever
point
immun
evas
mechan
shown
direct
impact
surviv
mous
model
blockag
type
ifn
pathway
enteroviru
infect
result
increas
mortal
viral
load
sever
infect
coxsackieviru
associ
host
express
decayacceler
factor
daf
coxsackieviru
adenoviru
receptor
car
shown
mous
model
facilit
coxsackieviru
infect
neural
stem
cell
daf
car
cell
surfac
receptor
protein
involv
complement
pathway
cell
adhes
respect
role
daf
diseas
known
car
function
receptor
use
coxsackievirus
enter
cell
immun
respons
enterovir
infect
vari
strain
specif
howev
gener
strong
proinflammatori
respons
involv
alongsid
increas
express
innat
immun
receptor
doubl
strand
rna
observ
case
respons
alongsid
viral
induc
lytic
cell
death
result
extens
necrosi
compound
inflammatori
respons
potenti
lead
condit
sepsi
interestingli
strain
enteroviru
seem
caus
particularli
high
degre
necrosi
pancreat
islet
cell
result
strong
correl
enterovir
infect
diabet
infect
shown
initi
distinct
innat
immun
respons
cn
infect
enterovir
infect
despit
similar
clinic
present
enterovir
respons
gener
stronger
level
almost
cytokin
higher
enterovir
respons
hpev
infect
hpev
infect
also
demonstr
strong
type
ifn
respons
gener
induc
rna
virus
addit
hpev
infect
demonstr
lower
level
express
enteroviru
infect
control
suggest
method
viral
immun
evas
result
mute
immun
respons
markedli
lower
innat
immun
cytokin
respons
induc
infect
interest
similar
clinic
present
mani
enterovir
infect
rais
question
diseas
pathogenesi
viral
classif
also
shown
hpev
detect
tlr
activ
type
ifn
pathway
evid
hpev
particular
hpev
type
employ
method
dampen
type
ifn
signal
cell
type
depend
manner
treatment
cell
type
ifn
howev
found
inhibit
viral
infect
cell
could
interest
explor
relev
evas
mechan
context
system
infect
immun
respons
hpev
infect
wellcharacteris
enterovir
infect
howev
certain
constant
suppress
type
ifn
immun
evas
mechan
indic
type
ifn
pathway
import
resolut
infect
data
analys
cytokin
popul
infect
context
sepsi
possibl
characteris
immun
respons
involv
infect
known
hold
true
viral
sepsi
sever
reason
propos
like
caus
sever
infect
hpev
observ
lack
sequenc
motif
present
hpev
thought
play
role
viral
use
integrin
host
cell
receptor
suggest
viru
may
exploit
differ
receptor
enter
cell
may
allow
easili
access
host
cell
thu
replic
higher
degre
hpev
also
note
effici
neutralis
antibodi
natur
gener
hpev
type
effici
neutralis
may
explain
infect
tend
sever
matern
antibodi
would
insuffici
neutralis
viru
neonat
result
sever
prolong
infect
recognit
influenza
viru
primarili
rigi
signal
induc
subsequ
immun
respons
polymorph
receptor
differ
individu
part
determin
suscept
sever
influenza
viru
infect
disrupt
alveolar
epithelialendotheli
barrier
lead
pulmonari
oedema
respiratori
insuffici
essenti
develop
sever
pneumonia
ard
caus
influenza
viru
influenza
viru
first
infect
alveolar
epitheli
cell
rather
alveolar
endotheli
cell
usual
primari
target
bacteriainduc
ard
influenza
viru
caus
apoptosi
epitheli
cell
upregul
fa
gene
via
activ
protein
kinas
r
addit
infect
epitheli
cell
produc
broad
rang
proinflammatori
cytokin
rant
cytokin
damag
epithelialendotheli
barrier
mechan
yet
fulli
understood
studi
demonstr
caus
decreas
activ
amiloridesensit
epitheli
sodium
channel
one
key
ion
channel
clear
alveolar
fluid
also
shown
abl
disrupt
tight
junction
epitheli
cell
cytokin
produc
epitheli
cell
caus
recruit
extravas
monocyt
neutrophil
direct
chemotaxi
upregul
adhes
molecul
eg
pselectin
eselectin
endotheli
cell
newlyrecruit
neutrophil
macrophag
deriv
monocyt
produc
wide
varieti
proinflammatori
cytokin
reactiv
oxygen
speci
nitric
oxid
induc
nitric
oxid
synthas
damag
barrier
cytokin
also
recruit
neutrophil
monocyt
alveolar
lumen
also
shown
posit
correl
concentr
neutrophil
bronchoalveolar
lavag
fluid
sever
ard
addit
macrophag
produc
protein
kinas
rand
fashion
express
tnfrelat
apoptosisinduc
ligand
trail
stimul
interact
trail
death
receptor
epitheli
cell
anoth
mechan
apoptosi
epitheli
cell
innat
immun
respons
dengu
infect
primarili
characteris
type
ifn
respons
activ
viru
degrad
endosom
acidif
dengu
viru
also
activ
rigi
signal
pathway
signal
type
ifn
also
evid
dengu
viru
may
signal
tlr
may
contribut
pathogenesi
extrem
inflamm
sever
dengu
type
ifn
induct
import
success
immun
respons
dengu
viru
mani
document
immun
evas
mechan
employ
dengu
viru
involv
inhibit
type
ifn
signal
method
dengu
viru
demonstr
inhibit
ifn
product
rigi
depend
mechan
inhibit
ifn
product
contribut
abil
dengu
viru
replic
spread
thu
caus
sever
system
infect
viral
sepsi
dengu
viru
also
caus
antibodi
enhanc
form
diseas
patient
expos
differ
serotyp
dengu
viru
one
initi
infect
enhanc
dengu
diseas
involv
immun
respons
nonenhanc
form
diseas
key
differ
presenc
crossreact
antibodi
neutralis
pathogen
instead
allow
viru
replic
within
fc
receptor
contain
cell
result
sever
infect
figur
summaris
aberr
immun
respons
viral
sepsi
becom
appar
recent
year
immunosuppress
result
sepsi
may
contribut
mortal
initi
hyperinflammatori
respons
immunosuppress
genotyp
patient
sepsi
correl
increas
mortal
also
recent
report
major
death
adult
occur
sepsi
caus
happen
third
day
later
death
could
attribut
nosocomi
infect
independ
predictor
third
day
later
death
corticosteroid
treatment
identif
pathogen
age
risk
factor
differ
paediatr
popul
death
occur
within
h
present
death
children
occur
due
refractori
shock
suggest
adult
sepsi
relat
death
due
initi
overpow
immun
respons
rather
due
inabl
control
infect
result
excess
pathogen
prolifer
inflamm
whilst
children
less
abl
surviv
initi
fulmin
infect
initi
inflammatori
immun
respons
characteris
viral
sepsi
usual
follow
period
immun
suppress
phenomenon
characteris
decreas
function
innat
adapt
immun
common
featur
includ
increas
express
neg
costimulatori
molecul
decreas
express
posit
costimulatori
molecul
cell
exhaust
apoptosi
effector
cell
increas
regulatori
cell
express
higher
number
myeloid
deriv
suppressor
cell
result
increas
infect
secondari
pathogen
also
reactiv
dormant
infect
natur
microbiota
becom
pathogen
particular
reactiv
herpesvirus
cmv
hsv
found
occur
immunocompet
patient
sever
infect
requir
hospitalis
respect
due
inabl
immun
system
adequ
control
erad
infect
often
result
sever
diseas
tissu
damag
even
death
mortal
sepsi
often
caus
seriou
secondari
infect
initi
inflamm
alreadi
pass
immun
suppress
common
featur
persist
seriou
viral
infect
viral
infect
directli
result
immun
suppress
strain
enteroviru
known
infect
leucocyt
particular
strain
coxsackieviru
enteroviru
implic
caus
sepsi
shown
capac
infect
leucocyt
sever
viral
infect
shown
result
immunosuppress
state
death
infect
leucocyt
result
diminish
abil
prime
cell
reduc
abil
control
pathogen
phagocytosi
greatli
increas
suscept
host
secondari
infect
compound
immun
suppress
effect
sever
infect
lymphocyt
exhaust
abil
handl
new
infect
becom
drastic
reduc
phenomenon
could
explain
higher
mortal
observ
infect
rel
immunosuppress
patient
well
high
level
mortal
observ
sepsi
initi
inflammatori
respons
pass
seriou
infect
caus
prolong
inflamm
often
result
immun
exhaust
found
vivo
experi
prolong
infect
larg
varieti
virus
result
decreas
differenti
immatur
lymphocyt
cell
prolong
viral
infect
result
decreas
express
turn
result
decreas
number
circul
memori
cell
also
observ
chronic
infect
lymphocyt
choriomening
viru
lcmv
result
poor
cell
respons
cytokin
stimul
poor
develop
memori
respons
similar
effect
observ
larg
number
mous
studi
suggest
chronic
viral
infect
could
impair
mani
aspect
effector
cell
function
chronic
viral
infect
found
differenti
abil
induc
immun
suppress
state
depend
strain
viru
mous
model
high
level
cell
exhaust
induc
infect
lcmv
hepat
b
viru
hepat
c
viru
hiv
less
pronounc
immun
exhaust
produc
mous
cell
infect
epsteinbarr
viru
ebv
measl
viru
cmv
differ
chronic
infect
produc
differ
degre
immun
suppress
wellunderstood
could
due
novel
immun
evas
mechan
case
hiv
rate
degre
replic
viru
prefer
replic
nich
degre
interact
prr
one
wellcharacteris
exampl
viral
induc
immunosuppress
found
measl
viru
measl
viru
sever
way
interact
immun
system
suppress
respons
one
interact
receptor
increas
apoptosi
immun
effector
cell
also
decreas
express
infect
measl
viru
also
shown
decreas
prolifer
lymphocyt
sever
week
initi
infect
one
studi
found
measl
viru
infect
may
immunosuppress
effect
host
immun
system
persist
year
although
mechan
may
occur
characteris
hypothesis
measl
viru
employ
method
deplet
memori
b
cell
result
heighten
suscept
infect
pathogen
process
multifactori
fulli
understood
one
propos
mechan
inhibit
cell
replic
measl
viru
protein
h
f
f
possibl
virus
may
utilis
immun
evas
mechan
may
result
immunosuppress
viral
reactiv
common
featur
form
sepsi
excess
inflamm
give
way
immun
exhaust
latent
infect
take
advantag
forgiv
environ
escap
immunolog
control
replic
herpesvirus
commonli
associ
phenomenon
owe
abil
becom
latent
mani
year
epidemiolog
studi
found
cmv
ebv
hsv
latent
around
nonpaediatr
popul
unit
state
respect
detect
viral
rna
indic
activ
replic
case
sepsi
occur
case
respect
reactiv
viral
infect
particularli
associ
increas
mortal
sepsi
viral
reactiv
associ
higher
mortal
sepsi
contribut
individu
virus
mortal
still
controversi
cmv
reactiv
associ
doubl
mortal
rate
compar
increas
mortal
rate
associ
latent
hiv
infect
sepsi
model
question
howev
possibl
increas
mortal
attribut
cmv
reactiv
could
due
reactiv
multipl
virus
simultan
one
studi
found
singl
viru
significantli
associ
higher
mortal
upon
reactiv
sepsi
found
reactiv
multipl
virus
significantli
associ
worsen
outcom
research
contribut
reactiv
individu
viru
strain
mortal
requir
also
hypothesis
viral
reactiv
may
contribut
feedback
loop
within
sepsi
wherein
reactiv
virus
contribut
even
cell
exhaust
immunosuppress
result
even
greater
suscept
viremia
compound
immun
suppress
elev
inflamm
feedback
loop
would
explain
high
degre
viral
reactiv
virus
correl
increas
mortal
still
unclear
whether
elev
viral
load
herpesvirus
follow
reactiv
inde
impair
lymphocyt
function
whether
side
effect
kind
immun
suppress
alreadi
take
place
demonstr
cmv
infect
effect
differenti
immatur
lymphocyt
effector
cell
howev
overal
effect
may
patient
wellcharacteris
state
differenti
brought
cmv
infect
similar
differenti
state
cell
older
adult
suggest
cmv
infect
may
contribut
immunosuppress
research
requir
confirm
effect
signific
effect
mortal
sever
infect
immunosuppress
effect
also
observ
ebv
infect
ebv
infect
found
associ
reduc
antibodi
respons
vaccin
gambian
infant
mechan
still
yet
known
interestingli
cmv
infect
found
associ
lower
respons
addit
evid
reactiv
viral
infect
contribut
inflamm
alongsid
immunosuppress
effect
result
heighten
state
inflamm
without
capac
resolv
particular
hsv
cmv
associ
inflammatori
respons
upon
reactiv
whether
phenomenon
contribut
significantli
mortal
sepsi
still
controversi
understand
role
viral
reactiv
play
immunosuppress
phase
patholog
sepsi
may
provid
avenu
treatment
futur
possibl
approach
would
applic
antivir
medic
specif
virus
commonli
experi
reactiv
drug
could
prevent
immun
exhaust
amelior
effect
like
inhibitor
neg
costimulatori
molecul
discuss
improv
understand
effect
viral
reactiv
vital
expand
understand
sepsi
contribut
better
categoris
ill
applic
appropri
treatment
diagnosi
viral
sepsi
use
inform
treatment
case
antivir
medic
avail
suitabl
howev
immunolog
data
scarc
viral
sepsi
said
certainti
viral
sepsi
meaning
differ
bacteri
sepsi
viral
sepsi
understood
insofar
immun
respons
involv
sever
viral
infect
understood
caus
charact
sepsi
highli
heterogen
knowledg
caus
pathogen
provid
treatment
option
pathogen
associ
immun
respons
sepsi
subtyp
thereof
characteris
well
enough
immun
responsebas
therapi
prolifer
enter
mainstream
import
next
step
understand
sepsi
characteris
group
sepsi
case
accord
criteria
may
inform
treatment
discoveri
cheap
effect
biomark
would
allow
criteria
defin
studi
conduct
aim
develop
method
discrimin
viral
bacteri
infect
analys
transcriptom
identifi
gene
signatur
differenti
viral
bacteri
infect
gene
identifi
studi
includ
gene
downstream
ifn
signal
pathway
ifnstimul
gene
protein
well
cytokin
role
gene
play
viral
infect
yet
known
howev
inform
requir
use
biomark
may
clinic
util
regardless
result
studi
may
inform
futur
research
identifi
biomark
use
clinic
set
quickli
differenti
bacteri
viral
infect
applic
method
case
sepsi
may
help
us
develop
understand
sepsi
differ
differ
aetiolog
transcriptom
studi
sepsi
perform
discuss
focus
studi
aim
understand
pathogen
role
charact
diseas
essenti
futur
sepsi
research
provid
answer
mysteri
viral
sepsi
may
prove
difficult
recruit
suffici
sampl
size
highli
power
transcriptom
studi
viral
sepsi
due
underdiagnosi
case
sepsi
cultur
neg
suggest
possibl
nonbacteri
caus
infect
appropri
test
perform
despit
howev
prefer
treatment
sepsi
case
earli
administr
broadspectrum
antibiot
surviv
rate
patient
present
septic
shock
decreas
averag
everi
hour
antimicrobi
appli
time
applic
antimicrobi
therapi
singl
greatest
indic
outcom
multivari
analysi
perform
one
studi
howev
administr
antibiot
effect
case
viral
sepsi
associ
advers
effect
understand
potenti
viral
caus
diseas
increas
possibl
treatment
option
open
possibl
use
broadspectrum
antivir
medic
also
treatment
built
understand
sepsi
immun
respons
pathogen
may
contribut
prospect
treatment
specif
virus
implic
sepsi
develop
pleconaril
antivir
enterovir
infect
inhibit
viral
attach
host
cell
receptor
prevent
uncoat
viral
nucleic
acid
data
suggest
drug
would
effect
safe
neonat
viral
induc
sepsi
drug
recent
complet
small
phase
clinic
trial
howev
longer
develop
avail
even
compassion
use
benefit
effect
antivir
medicin
clear
could
help
case
sever
viral
infect
sepsi
also
provid
treatment
benign
infect
could
prove
use
use
drug
alongsid
antibiot
sepsi
case
allow
possibl
viral
caus
although
would
also
open
possibl
develop
viral
resist
mani
specif
antivir
drug
develop
gone
trial
howev
none
yet
test
specif
sepsi
exampl
may
benefici
present
sepsi
certain
situat
includ
acyclovir
proven
effect
hsv
infect
amantadin
rimantadin
oseltamivir
zanamivir
influenza
broadspectrum
antivir
drug
like
ribavirin
favipiravir
antivir
medicin
may
also
role
treatment
viral
reactiv
may
improv
outcom
even
nonvir
induc
sepsi
ganciclovir
demonstr
measur
decreas
cmv
reactiv
mice
howev
human
trial
show
signific
decreas
cmvinduc
inflammatori
cytokin
level
numer
drug
develop
cmv
could
effect
prevent
viral
reactiv
advent
research
personalis
medicin
idea
treat
host
immun
respons
sepsi
becom
popular
understand
host
respons
pathogen
modifi
may
prevent
seriou
infect
result
sepsi
sepsislikeil
one
common
strategi
treat
host
respons
use
immunomodulatori
molecul
prevent
harm
excess
inflamm
infect
immunomodul
sepsi
aim
decreas
harm
effect
excess
inflamm
alter
counteract
effect
inflammatori
mediat
molecul
use
broad
antiinflammatori
molecul
corticosteroid
trial
immunomodulatori
drug
howev
fail
approach
fallen
favour
recent
year
either
prove
ineffect
eg
dengu
case
opposit
desir
effect
dampen
immun
system
way
allow
pathogen
freedom
replic
prolifer
uncontrol
infect
caus
greater
harm
eg
corticosteroid
influenza
howev
adjunct
corticosteroid
therapi
may
benefici
consid
patient
varicella
zoster
viru
enceph
hsv
enceph
recent
year
immunostimulatori
approach
immunotherapi
sepsi
becom
much
popular
approach
aim
promot
rapid
pathogen
clearanc
decreas
chanc
prolifer
caus
sever
infect
one
propos
method
select
applic
immunostimulatori
cytokin
granulocytemacrophag
colonystimul
factor
gmcsf
studi
shown
contribut
effect
viral
clearanc
recent
studi
demonstr
major
death
occur
due
sepsi
occur
third
day
later
immunosuppress
taken
hold
suggest
immunostimulatori
approach
may
prove
benefici
order
treatment
immun
respons
work
meaning
way
decreas
overal
mortal
must
better
understand
immun
respons
infect
contribut
develop
sepsi
end
develop
biomark
could
determin
likelihood
infect
becom
harm
due
lack
abil
clear
infect
inde
whether
initi
immun
respons
excess
harm
would
make
rel
brute
forc
treatment
much
effect
time
target
applic
understand
excess
inflammatori
respons
pathogen
allow
us
better
categoris
sepsi
state
group
accord
treatabl
stride
forward
made
field
studi
identifi
two
distinct
host
respons
signatur
sepsi
unsupervis
hierarch
cluster
one
significantli
associ
higher
mortal
studi
analys
bacteri
sepsi
methodolog
would
extrem
use
expand
understand
viral
sepsi
identifi
signatur
characteris
rel
immunosuppress
well
increas
toler
endotoxin
lymphocyt
exhaust
metabol
dysfunct
hypothesis
individu
experienc
sever
diseas
due
inabl
control
infect
result
increas
pathogen
replic
individu
would
also
suscept
secondari
infect
studi
howev
examin
sepsi
adult
patient
commun
acquir
pneumonia
necessarili
inform
paediatr
popul
immatur
immun
system
immunocompromis
group
viral
infect
similar
studi
focus
primarili
viral
sepsi
would
invalu
understand
viral
sepsi
would
open
numer
new
avenu
prospect
treatment
effect
clinic
set
approach
requir
develop
rapid
transcriptom
analysi
method
clinic
use
case
patient
acut
present
sepsi
anoth
studi
aim
identifi
predict
genom
signatur
similar
result
group
case
sepsi
use
hierarch
cluster
method
two
distinct
subgroup
one
correl
higher
rate
mortal
characteris
immunosuppress
phenotyp
gene
involv
function
lymphocyt
suppress
despit
rel
high
lymphocyt
count
patient
group
studi
similar
limit
studi
mention
knowledg
could
potenti
use
inform
treatment
develop
immunotherapeut
suggest
patient
present
immunosuppress
gene
express
signatur
may
benefit
drug
modul
aspect
immun
respons
exampl
treatment
variou
cytokin
blockad
receptor
induc
cell
death
lymphocyt
program
death
ligand
promis
target
treatment
viral
sepsi
implic
develop
immunosuppress
phase
sepsi
induc
apoptosi
effector
cell
continu
elev
express
septic
patient
found
correl
highli
patient
mortal
implic
pathogenesi
highli
pathogen
influenza
infect
sever
influenza
infect
express
higher
level
block
led
increas
number
reduc
viral
titr
vivo
block
may
allow
vastli
improv
clearanc
seriou
viral
infect
prevent
patient
becom
septic
blockad
treatment
may
also
use
immunosuppress
phase
sepsi
maintain
compet
immun
system
clear
secondari
infect
thu
decreas
overal
mortal
one
common
featur
sepsi
emerg
promis
target
treatment
dysregul
endotheli
barrier
endotheli
barrier
continu
layer
coat
vascular
system
separ
fluid
tissu
compart
barrier
import
maintain
bodili
homeostasi
regul
passag
gase
liquid
protein
cell
microorgan
among
thing
blood
tissu
dysregul
found
central
patholog
sepsi
state
septic
shock
tight
junction
cell
becom
disrupt
due
platelet
neutrophil
adher
endotheli
wall
releas
inflammatori
toxic
mediat
cell
increas
express
bind
molecul
like
selectin
integrin
allow
leucocyt
bind
endotheli
layer
migrat
process
dysregul
also
compound
damag
endotheli
barrier
increas
level
inflammatori
mediat
surfac
lead
fluid
leak
interstiti
tissu
recruit
macrophag
inflammatori
cell
tissu
normal
access
result
tissu
damag
respons
gener
allow
immun
effector
cell
reach
site
localis
infect
damag
dysregul
move
away
homeostasi
occur
sepsi
allow
consider
damag
done
tissu
phenomenon
found
also
occur
seriou
viral
infect
also
play
major
role
patholog
viral
sepsi
case
virus
hantaviru
dengu
virus
hsv
present
suggest
role
endotheli
barrier
pathogenesi
seriou
diseas
lack
data
relev
endotheli
leak
viral
infect
howev
evid
involv
pathogenesi
avian
influenza
viru
produc
cytokin
storm
effect
known
increas
vascular
permeabl
immun
cell
infiltr
tissu
therefor
endotheli
barrier
dysfunct
present
attract
target
treatment
sever
viral
infect
sepsi
sever
drug
known
help
preserv
endotheli
integr
may
use
treat
sever
viral
infect
sepsi
includ
common
medic
statin
angiotensin
receptor
blocker
proven
benefit
sepsi
influenza
critic
ill
thought
work
maintain
restor
endotheli
barrier
integr
could
promis
treatment
viral
infect
known
disrupt
endotheli
integr
drug
success
treat
sever
viral
infect
ebola
influenza
suggest
use
viral
sepsi
promis
area
futur
research
one
trial
aim
control
sever
sepsi
use
drug
atorvastatin
trial
abort
due
subpar
recruit
demonstr
interest
result
calcul
assum
drug
would
bring
reduct
case
progress
sepsi
patient
would
requir
achiev
statist
signific
quarter
number
recruit
decreas
progress
sepsi
caus
observ
far
exceed
expect
howev
due
insuffici
sampl
size
result
insignific
addit
data
result
would
suggest
statin
may
particularli
promis
rout
research
particularli
case
virus
known
interfer
endotheli
barrier
function
viral
sepsi
continu
underdiagnos
heterogen
form
sepsi
caus
wide
varieti
virus
common
pathogen
hsv
enterovirus
hpev
influenza
dengu
virus
popul
much
higher
risk
viral
sepsi
other
mani
reason
popul
highest
risk
young
children
pregnant
women
older
adult
immunosuppress
individu
heighten
risk
sever
due
rel
immunosuppress
present
popul
virus
often
caus
viral
sepsi
tend
capac
evad
kill
immun
system
still
induc
power
inflammatori
respons
often
characteris
high
level
express
alongsid
low
express
damag
host
prolong
inflamm
brought
infect
result
immunosuppress
state
reduc
bodi
capac
clear
infect
drastic
increas
risk
death
origin
viral
infect
newli
acquir
infect
reactiv
infect
understand
viral
caus
sepsi
immun
respons
common
viral
infect
could
lead
improv
treatment
sepsi
use
specif
antivir
medic
futur
may
possibl
appli
immunotherapi
built
around
understand
specif
viral
infect
either
aid
viral
clearanc
reduc
harm
viral
infect
sepsi
differ
caus
seem
differ
littl
clinic
present
howev
use
modern
transcriptom
method
demonstr
meaning
differ
immun
respons
may
use
distinguish
viral
bacteri
sepsi
may
aid
develop
futur
immunomodulatori
drug
